色av一区二区,日本黄色不卡,中文字幕12页

熱門搜索化學(xué)品最多只顯示前20條，請(qǐng)點(diǎn)擊“搜索化學(xué)品”查看所有結(jié)果

CAS登錄號(hào)

中文名

英文名

分子結(jié)構(gòu)式

分子式

詳情

供應(yīng)商

58-49-1

血管緊張素

Angiotensin acetate;
Alanine,N-[1-[N-[N-[N-[N-(N2-L-a-aspartyl-L-arginyl)-L-valyl]-L-tyrosyl]-L-valyl]-L-histidyl]-L-prolyl]-3-phenyl-,L- (6CI,7CI);
1-Asp-5-Val-angiotensin II;
1-L-Asparticacid-5-valine-angiotensin II;
1-a-L-Aspartic acid-5-L-valine-angiotensin II;
11: PN: US20090227507 SEQID:20 unclaimed protein;
11: PN: US6762167 SEQID: 19 unclaimed sequence;
16: PN:WO0144270 SEQID: 19 claimed protein;
178: PN: WO2008004992 SEQID: 42 unclaimedsequence;
17: PN: US20080293634 SEQID: 24 unclaimed sequence;
17: PN: WO0143761SEQID: 19 claimed protein;
17: PN: WO0155176 SEQID: 19 claimed protein;
17: PN:WO02087504 SEQID: 19 claimed protein;
18: PN: WO0002905 SEQID: 19 claimedprotein;
18: PN: WO0198325 SEQID: 19 claimed protein;
19: PN: US20030130196SEQID: 19 claimed protein;
19: PN: WO0056345 SEQID: 19 claimed sequence;
23:PN: WO0069900 SEQID: 672 unclaimed sequence;
23: PN: WO9958140 SEQID: 19 claimedsequence;
24: PN: WO0069900 SEQID: 673 unclaimed sequence;
4: PN: WO0187976PAGE: 16 unclaimed sequence;
5-L-Valine angiotensin II;
5-Valine-angiotensinII;
Angiotensin II(Alligator mississippiensis);
Angiotensin II (ox);
Angiotensin II 5-valine;
L-Aspartyl-L-arginyl-L-valyl-L-tyrosyl-L-valyl-L-histidyl-L-prolyl-L-phenylalanine;
L-Phenylalanine, N-[1-[N-[N-[N-[N-(N2-L-a-aspartyl-L-arginyl)-L-valyl]-L-tyrosyl]-L-valyl-]-L-histidyl]-L-prolyl]-;
Valine angiotensin II;
[Val5] Angiotensin II, human;

醋酸增血壓素

Angiotensin acetate

C49H70N14O11.2(C2H4O2)

詳情

供應(yīng)商

53-73-6

增血壓素

Angiotensin II,1-L-asparagine-5-L-valine-;
Alanine,N-[1-[N-[N-[N-[N-(N2-L-asparaginyl-L-arginyl)-L-valyl]-L-tyrosyl]-L-valyl]-L-histidyl]-L-prolyl]-3-phenyl-,L- (6CI,7CI);
1-Asn2-5-Val-angiotensin II;
1-Asparagine-5-valineangiotensin II;
1-Asparaginyl-5-valyl-angiotensin II;
1-Aspartic acid-5-valine angiotensin IIamide;
1-Aspartic acid-b-amide 5-valine angiotensin II;
1-L-Asn-5-L-Val-angiotensin II;
1-L-Asparagine-5-L-valineangiotensin II;
1-L-Asparagine-5-L-valine-angiotensin;
1-L-Asparaginyl-5-L-valyl angiotensin octapeptide;
1-a-Asparagine-5-valine-angiotensinII;
12: PN: US20090227507 SEQID: 21 unclaimed protein;
12: PN: US6762167 SEQID:20 unclaimed sequence;
17: PN: WO0144270 SEQID: 20 claimed protein;
18: PN:WO0143761 SEQID: 20 claimed protein;
18: PN: WO0155176 SEQID: 20 claimedprotein;
18: PN: WO02087504 SEQID: 20 claimed protein;
19: PN: WO0002905 SEQID:20 claimed protein;
19: PN: WO0198325 SEQID: 20 claimed protein;
20: PN:US20030130196 SEQID: 20 claimed protein;
20: PN: WO0056345 SEQID: 20 claimedsequence;
24: PN: WO9958140 SEQID: 20 claimed protein;
5-L-Valine-angiotensinII amide;
5-Valine angiotensin II amide;
5-Valine angiotensin II aspartic-b-amide;
5-Valine angiotensinamide II;
5-Valine-angiotensin II-b-amide;
5-Valyl angiotensin II amide;
545: PN: US20090175821 SEQID: 655claimed protein;
6: PN: WO0069900 SEQID: 655 unclaimed sequence;
Angiotensin(Ciba);
Angiotensin II (Oncorhynchus mykiss);
Angiotensin II (eel);
AngiotensinII amide;
Angiotensin II amide 5-valine;
Angiotensin II amide, 5-L-valine-;
Angiotensin II aspartic-b-amide, 5-L-valine;
Angiotensin II-5-valine-amide;
Angiotensin amide;
Angiotensin amide, 5-L-valine-;
Hypertensin;
Hypertensinamide;
Hypertensine;
Ipertensina;
L-Phenylalanine,N-[1-[N-[N-[N-[N-(N2-L-asparaginyl-L-arginyl)-L-valyl]-L-tyrosyl]-L-valyl]-L-histidyl]-L-prolyl]-;
NSC 107678;
Rainbow trout angiotensin II;
Val-Hypertensin-II-asp-b-amide;
Val5-angiotensin II amide

Brevetoxin A;
Brevetoxin1;
Brevetoxin PbTx 1;
GB 1;
PbTx 1;
Ptychodiscus brevis toxin 1

Vasopressin,1-(3-mercapto-3-methylbutanoic acid)-2-(O-methyl-L-tyrosine)-8-D-arginine-(9CI);
1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane,cyclic peptide deriv.

Vasopressin,N-L-alanyl-8-L-arginine- (9CI);
1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane,cyclic peptide deriv.

MCA-PRO-LEU-GLY-LEU-DAP(DNP)-ALA-ARG-NH2;
MCA-PRO-LEU-GLY-LEU-DAP-ALA-ARG-NH2: MCA-PLGL-DAP-AR-NH2

MCA-PRO-LEU-GLY-LEU-DAP(DNP)-ALA-ARG-NH2;
MOCAC-PRO-LEU-GLY-LEU-[3-DNP-2,3-DAP]-ALA-ARG, AMIDE;
MOCAC-PRO-LEU-GLY-LEU-A2PR(DNP)-ALA-ARG-NH2;
MOCAC-PRO-LEU-GLY-LEU-N3-[2,4-DINITROPHENYL]-L-2,3-DIAMINOPROPIONYL-ALA-ARG-NH2;
MMP-2/MMP-7 SUBSTRATE;
MMP-2/MMP-7 SUBSTRATE, FLUOROGENIC;
390 MMP FRET SUBSTRATE I;
(7-METHOXYCOUMARIN-4-YL)ACETYL-L-PROLYL-L-LEUCYLGLYCYL-L-LEUCYL-[N-BETA-(2,4-DINITROPHENYL)-L-2,3-DIAMINOPROPIONYL]-L-ALANYL-L-ARGININE AMIDE;
7-METHOXYCOUMARIN-4-ACETYL-PRO-LEU-GLY-LEU-BETA-(2,4-DINITROPHENYLAMINO)ALA-ALA-ARG AMIDE

腎上腺素環(huán)杷明;
腎上腺素環(huán)杷明

BODIPY CYCLOPAMINE

無

C49H70BF2N5O4

詳情

供應(yīng)商

化工產(chǎn)品